Sodium-Glucose Cotransporter-2 Inhibitors and Severe Urinary Tract Infections: Reassuring Real-World Evidence
- PMID: 31357211
- DOI: 10.7326/M19-1950
Sodium-Glucose Cotransporter-2 Inhibitors and Severe Urinary Tract Infections: Reassuring Real-World Evidence
Comment on
-
Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections: A Population-Based Cohort Study.Ann Intern Med. 2019 Aug 20;171(4):248-256. doi: 10.7326/M18-3136. Epub 2019 Jul 30. Ann Intern Med. 2019. PMID: 31357213 Free PMC article.
Similar articles
-
Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections.Ann Intern Med. 2019 Dec 17;171(12):944-945. doi: 10.7326/L19-0671. Ann Intern Med. 2019. PMID: 31842209 No abstract available.
-
Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections.Ann Intern Med. 2019 Dec 17;171(12):943-944. doi: 10.7326/L19-0670. Ann Intern Med. 2019. PMID: 31842208 No abstract available.
-
Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections.Ann Intern Med. 2019 Dec 17;171(12):944. doi: 10.7326/L19-0669. Ann Intern Med. 2019. PMID: 31842207 No abstract available.
-
Sodium-glucose cotransporter-2 inhibitors and genital and urinary tract infections in type 2 diabetes.Postgrad Med. 2016 May;128(4):409-17. doi: 10.1080/00325481.2016.1167570. Epub 2016 Apr 4. Postgrad Med. 2016. PMID: 26982554 Review.
-
Perioperative Considerations for the Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes.Anesth Analg. 2018 Feb;126(2):699-704. doi: 10.1213/ANE.0000000000002377. Anesth Analg. 2018. PMID: 28786838 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical